• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Amgen terminates the Novartis contract.

Quote




























anonymous said:
Fuck Novartis - Amgen here. We biotech and you are loser pharma! Now die
Click to expand...


You must be 12 with your language. Your comment reflects on your pompous attitude from your leadership. “We biotech”..Laughable. Your Neuro relationships brought to you by Novartis. I hope we do separate due to ignorant people with your mindset.
We are all the same .. do you think hcps see it differently? Your delusional otherwise.

Thanks for the laugh
 




anonymous said:
You must be 12 with your language. Your comment reflects on your pompous attitude from your leadership. “We biotech”..Laughable. Your Neuro relationships brought to you by Novartis. I hope we do separate due to ignorant people with your mindset.
We are all the same .. do you think hcps see it differently? Your delusional otherwise.

Thanks for the laugh
Click to expand...

the problem is Novartis isn't respected in the neurologist community- general statement of course I'm sure someone in Novartis has some decent relationships- you guys run with a calls per day reach and frequency BS and follow some stupid sales model- and our coached to it. You will never succeed in specialty sales with metrics and leadership pushing reps to do that type of stuff. I'm in the Northeast and I can say for sure, 100% that Novartis has very little relationships or anything really going in neurology. The fact of the matter is we don't need you as much as you need us.
 




anonymous said:
the problem is Novartis isn't respected in the neurologist community- general statement of course I'm sure someone in Novartis has some decent relationships- you guys run with a calls per day reach and frequency BS and follow some stupid sales model- and our coached to it. You will never succeed in specialty sales with metrics and leadership pushing reps to do that type of stuff. I'm in the Northeast and I can say for sure, 100% that Novartis has very little relationships or anything really going in neurology. The fact of the matter is we don't need you as much as you need us.
Click to expand...


Yep because your shit show company has done so well with Repatha bahahahahahaha. You clowns can't sell shit good luck on your own. It will be like watching the Titanic go down.
 




anonymous said:
the problem is Novartis isn't respected in the neurologist community- general statement of course I'm sure someone in Novartis has some decent relationships- you guys run with a calls per day reach and frequency BS and follow some stupid sales model- and our coached to it. You will never succeed in specialty sales with metrics and leadership pushing reps to do that type of stuff. I'm in the Northeast and I can say for sure, 100% that Novartis has very little relationships or anything really going in neurology. The fact of the matter is we don't need you as much as you need us.
Click to expand...
Novartis is not respected anywhere anymore because of terrible upper management decisions. No one is seasoned anymore and Vas is a joke. His lack of knowledge, expertise and behavior is responsible and the people he decides to keep are shit. The decisions are wrong internally. Poor reps can beat their chest and abuse others but they are nothing in the chain of command and one day they will know when they are kicked out.
 




It's beyond a shitshow in medical Novartis. No surprises that Amgen would want to disconnect. The "neuroscience" group were led by an idiot. His boss is an even bigger one and she is being elevated into a puppet global role. Waste of time meetings, ass coverings etc the usual BS only worse because its the land of snakes and fools of Novartis.

Vas is seen as a narcissistic leader with a fake friendly style who makes ridiculous statements about changing how managers lead without providing ANY tangible changes. The only changes have been to slow down hiring, to slow down the ability to bring on contractors, and so on.

The place is becoming more and more like old East Germany with those who stay become more hardened, entrenched, and rigid, with a complete lack of inspiration or integrity.

We're all trying to get out somehow.
 








anonymous said:
the problem is Novartis isn't respected in the neurologist community- general statement of course I'm sure someone in Novartis has some decent relationships- you guys run with a calls per day reach and frequency BS and follow some stupid sales model- and our coached to it. You will never succeed in specialty sales with metrics and leadership pushing reps to do that type of stuff. I'm in the Northeast and I can say for sure, 100% that Novartis has very little relationships or anything really going in neurology. The fact of the matter is we don't need you as much as you need us.
Click to expand...

Interesting comment because before we got in bed with Amgen we didn't follow any bs metrics and were considered sales specialists. Then we launched Aimovig with ya'll and that was the beginning of the end. And we just launched a new molecule in MS and have another in our pipeline. Obviously you don't know shit...which is so typical of Amgen reps.
 








anonymous said:
Interesting comment because before we got in bed with Amgen we didn't follow any bs metrics and were considered sales specialists. Then we launched Aimovig with ya'll and that was the beginning of the end. And we just launched a new molecule in MS and have another in our pipeline. Obviously you don't know shit...which is so typical of Amgen reps.
Click to expand...

Just because we have a nice pipeline doesn’t mean we run sales efficiently
 




anonymous said:
Just because we have a nice pipeline doesn’t mean we run sales efficiently
Click to expand...
Nice pipeline? What are you smoking? Are you one of those crappy managers who do nothing but act like you work. Finding things to do and making yourself visible. Which ones are genuine and ready to launch in the next few years? None?
 




Hey, wasn't Vas the GLOBAL Head of Biopharmaceuticals & Oncology Injectables at Sandoz International GmbH, but he had no idea Sandoz was churning out a competitors antibody, come on, doesn't he communicate with his Sandoz buddies anymore?
 








What has happened to this company? Between Joey J paying off Trump for insider information, and Vas covering up the Sandoz-Alder deal for a few dollars more, the company has gone to shit, and the board members sit on their asses doing nothing.
 




Top Bottom
Back
Quote